Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier

被引:157
作者
Chae, SY
Son, S
Lee, M
Jang, MK
Nah, JW
机构
[1] Sunchon Natl Univ, Dept Polymer Sci & Engn, Jeonnam 540742, South Korea
[2] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea
关键词
chitosan oligosaccharide (COS); self-aggregation; deoxycholic acid; nanoparticle; gene;
D O I
10.1016/j.jconrel.2005.09.040
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To develop chitosan based efficient gene carriers, highly purified chitosan oligosaccharides (COSs) were chemically modified with deoxycholic acid (DOCA). Owing to the amphiphilic characters, the DOCA-conjugated COSs (COSDs) formed self-aggregated nanoparticles in aqueous milieu. The physicochemical characterization revealed that the particle size of the nanoparticles was in the range of 200 similar to 240 nm and the critical aggregation concentration (cacs) was 0.012 similar to 0.046 g/L, depending on the degree of substitution (DS). As efficient gene carriers, the COSD nanoparticles showed superior gene condensation and protection of condensed gene from endonuclease attack than unmodified COSs. Furthermore, COSDs showed great potential for gene carrier with the high level of gene transfection efficiencies, even in the presence of serum. Considered with the negligible cytotoxic effects, DOCA-modified chitosan oligosaccharides can be considered as potential candidates for efficient non-viral gene carriers. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:330 / 344
页数:15
相关论文
共 37 条
[11]   Water-soluble lipopolymer for gene delivery [J].
Han, SO ;
Mahato, RI ;
Kim, SW .
BIOCONJUGATE CHEMISTRY, 2001, 12 (03) :337-345
[12]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[13]   Mechanism of cell transfection with plasmid/chitosan complexes [J].
Ishii, T ;
Okahata, Y ;
Sato, T .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1514 (01) :51-64
[14]   A method for oral DNA delivery with N-acetylated chitosan [J].
Kai, E ;
Ochiya, T .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :838-843
[15]   Implantable applications of chitin and chitosan [J].
Khor, E ;
Lim, LY .
BIOMATERIALS, 2003, 24 (13) :2339-2349
[16]   Efficient gene delivery by urocanic acid-modified chitosan [J].
Kim, TH ;
Ihm, JE ;
Choi, YJ ;
Nah, JW ;
Cho, CS .
JOURNAL OF CONTROLLED RELEASE, 2003, 93 (03) :389-402
[17]   Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers [J].
Köping-Höggård, M ;
Vårum, KM ;
Issa, M ;
Danielsen, S ;
Christensen, BE ;
Stokke, BT ;
Artursson, P .
GENE THERAPY, 2004, 11 (19) :1441-1452
[18]   Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo [J].
Köping-Höggård, M ;
Mel'nikova, YS ;
Vårum, KM ;
Lindman, B ;
Artursson, P .
JOURNAL OF GENE MEDICINE, 2003, 5 (02) :130-141
[19]   Chitosan as a nonviral gene delivery system.: Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo [J].
Köping-Höggård, M ;
Tubulekas, I ;
Guan, H ;
Edwards, K ;
Nilsson, M ;
Vårum, KM ;
Artursson, P .
GENE THERAPY, 2001, 8 (14) :1108-1121
[20]   Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid [J].
Kwon, S ;
Park, JH ;
Chung, H ;
Kwon, IC ;
Jeong, SY ;
Kim, IS .
LANGMUIR, 2003, 19 (24) :10188-10193